These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 4983442)
21. [On the use of vitamin E nicotinate in cerebral diseases caused by debilitation]. Poggi E; Sforzini D; Tosarelli L Sist Nerv; 1971; 23(7):126-32. PubMed ID: 5005842 [No Abstract] [Full Text] [Related]
22. Chronic cerebrovascular insufficiency in the elderly. Perspectives on treatment. Rosen HJ J Med Soc N J; 1972 May; 69(5):445-8. PubMed ID: 4623096 [No Abstract] [Full Text] [Related]
23. [Trial of eutergine in chronic cerebral arteriopathies]. Pauchant M; Bernard JM Lille Med; 1972 May; 17():Suppl 4:819-23. PubMed ID: 4626797 [No Abstract] [Full Text] [Related]
24. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina]. Brüning G Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634 [No Abstract] [Full Text] [Related]
26. Dihydrogenated alkaloids of ergot in geriatric patients: symptomatic treatment of cerebrovascular insufficiency. Kaye C Bol Asoc Med P R; 1972 Nov; 64(11):301-3. PubMed ID: 4205800 [No Abstract] [Full Text] [Related]
27. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age]. Andalò L; Missana M Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202 [No Abstract] [Full Text] [Related]
28. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly. Rao DB; Norris JR Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959 [No Abstract] [Full Text] [Related]
29. [Mental effects of Wallerox therapy in the aged]. Thomae H Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216 [No Abstract] [Full Text] [Related]
30. [Electroencephalographic alterations after administration of vaso-active substance (Hydergine)]. Pires de Oliveira RS Arq Neuropsiquiatr; 1973 Jun; 31(2):107-22. PubMed ID: 4198581 [No Abstract] [Full Text] [Related]
31. [Interpretation of the clinical signs in the light of recent acquisitions]. Heyck H Minerva Med; 1968 Dec; 59(96):5200-6. PubMed ID: 4974812 [No Abstract] [Full Text] [Related]
32. Influence of treatment on symptomatology and correlated electroencephalographic (EEG) changes in the aged. Arrigo A; Braun P; Kauchtschischwili GM; Moglia A; Tartara A Curr Ther Res Clin Exp; 1973 Jul; 15(7):417-26. PubMed ID: 4198303 [No Abstract] [Full Text] [Related]
33. [The effect of redergam on the cerebral circulation of patients who have suffered insults]. Khadzhiev D Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):33-7. PubMed ID: 4976423 [No Abstract] [Full Text] [Related]
34. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69]. Laveant-Hebrard C; Camus JP Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868 [No Abstract] [Full Text] [Related]
35. [Study of Iskedyl in otoneurologic ischemia]. Duchamps B JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):649-53. PubMed ID: 4280429 [No Abstract] [Full Text] [Related]
36. [Treatment of cerebral vascular diseases due to softening]. Tomaselli R; Elia C Omnia Med Ther; 1968; 46(3):657-70. PubMed ID: 4989937 [No Abstract] [Full Text] [Related]
37. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine]. Henriet M; Jacquy J; Noel G Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548 [No Abstract] [Full Text] [Related]
38. [Note on the use of dihydrogenated derivatives of ergotoxin (Hydergine) and their association with psychopharmacology in the treatment of aged neuropsychiatric patients]. Bertolotti P; Spaggiari G Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1243-58. PubMed ID: 4968439 [No Abstract] [Full Text] [Related]